Funds

Fidelity Advisor Biotechnology Fund - Class C

FBTCX

Fidelity Advisor Biotechnology Fund - Class C

Actions
  • Price (USD)23.44
  • Today's Change0.13 / 0.56%
  • 1 Year change+33.33%
Data delayed at least 15 minutes, as of Nov 20 2024.
More ▼
Find Funds and ETFs
Find Funds and ETFs
Use our fund screener to discover other asset types.
 
Funds ScreenerGo to the Funds Screener

Trailing total returns

Daily
5 years3 years1 year6 months3 months1 month
Fidelity Advisor Biotechnology Fund - Class C+12.01%+5.49%+51.79%+18.82%+3.71%+0.42%
Health+7.46%-2.46%+25.19%+6.99%-1.64%-3.51%
S&P 500 TR USD+15.27%+9.08%+38.02%+14.08%+3.66%-0.91%
Fund quartile1st1st1st1st1st1st
Funds in category146160174178180180
As of Oct 31 2024.

Trailing returns analysis

3M

The chart shows how frequently the fund's 3M return is positive or negative. Each bar is an observation period (the fund's return over the past 3M, at month's end).

The performance data shown in tables and graphs on this page is calculated in USD of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.
All managed funds data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2024
All Rights reserved
© 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.